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Background: The purpose of the present study was to evaluate the effects of PCSO-524®, a marine oil lipid and n-3
LC PUFA blend, derived from New Zealand green- lipped mussel (Perna canaliculus), on markers of muscle damage
and inflammation following muscle damaging exercise in untrained men.
Methods: Thirty two untrained male subjects were randomly assigned to consume 1200 mg/d of PCSO- 524®
(a green-lipped mussel oil blend) or placebo for 26 d prior to muscle damaging exercise (downhill running), and
continued for 96 h following the muscle damaging exercise bout. Blood markers of muscle damage (skeletal muscle
slow troponin I, sTnI; myoglobin, Mb; creatine kinase, CK), and inflammation (tumor necrosis factor, TNF-α), and
functional measures of muscle damage (delayed onset muscle soreness, DOMS; pressure pain threshold, PPT; knee
extensor joint range of motion, ROM; isometric torque, MVC) were assessed pre- supplementation (baseline), and
multiple time points post-supplementation (before and after muscle damaging exercise). At baseline and 24 h
following muscle damaging exercise peripheral fatigue was assessed via changes in potentiated quadriceps twitch
force (ΔQtw,pot) from pre- to post-exhaustive cycling ergometer test in response to supra-maximal femoral nerve
stimulation.
Results: Compared to placebo, supplementation with the green-lipped mussel oil blend significantly attenuated
(p < 0.05) sTnI and TNF-α at 2, 24, 48, 72 and 96 h., Mb at 24, 48, 72, 96 h., and CK-MM at all-time points following
muscle damaging exercise, significantly reduced (p < 0.05) DOMS at 72 and 96 h post-muscle damaging exercise,
and resulted in significantly less strength loss (MVC) and provided a protective effect against joint ROM loss at 96 h
post- muscle damaging exercise. At 24 h after muscle damaging exercise perceived pain was significantly greater
(p < 0.05) compared to baseline in the placebo group only. Following muscle damaging exercise ΔQtw,pot was
significantly less (p < 0.05) on the green-lipped mussel oil blend compared to placebo.
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Conclusion: Supplementation with a marine oil lipid and n-3 LC PUFA blend (PCSO-524®), derived from the New
Zealand green lipped mussel, may represent a useful therapeutic agent for attenuating muscle damage and
inflammation following muscle damaging exercise.
Keywords: Omega-3 fatty acids, Green-lipped mussel oil blend, Muscle damage, DOMS, EccentricIntroduction
Exercise-induced muscle damage (EIMD) can be caused
by eccentric type or unaccustomed (novel) exercise, and
results in decrements in muscle force production, devel-
opment of delayed-onset muscle soreness (DOMS) and
swelling, rise in passive tension, and an increase in blood
intramuscular proteins [1]. Delayed-onset muscle soreness
is generally considered a hallmark sign of EIMD [2], and it
is thought that DOMS is partially related to direct muscle
fiber damage, and its magnitude appears to vary with the
type, duration and intensity of exercise [3]. The inflamma-
tory response to EIMD results in the release into blood of
reactive species from both neutrophils and macrophages,
and an array of cytokines from the injured muscle includ-
ing tumor necrosis factor (TNF)-α, interleukin (IL)-1β
and IL-6, which contribute to a low-grade systemic in-
flammation and oxidative stress [4]. The pro- inflamma-
tory and pro-oxidant response can provoke secondary
tissue damage [5], thus prolonging the regenerative process,
which is generally characterized by a restoration of muscle
strength and resolution of inflammation [5].
Exercise-induced muscle damage and DOMS can po-
tentially hinder performance in activities ranging from
basic physical activity to athletic training and competi-
tion. There are a number of strategies that have been
used to attenuate EIMD and DOMS such as anti-
inflammatory medication, cryotherapy, massage, stretch-
ing, hyperbaric oxygen, homeopathy, ultrasound, rest,
light exercise and electrotherapeutic modalities [3]. The
use of non-steroidal anti- inflammatory drugs (NSAIDs)
and continued exercise appear to be the most commonly
used methods to treat DOMS [1]. However, while the use
of NSAIDs has been shown to decrease perceived muscle
soreness and pain associated with DOMS, they fail to im-
pact the length or degree of muscle weakness [6], may be
detrimental to muscle cell repair and adaptation by de-
creasing satellite cell activity [7], and have been shown to
suppress the protein synthesis response in skeletal muscle
after eccentric resistance exercise [8]. Due to the fact that
there appears to be no completely effective treatment for
preventing/reducing EIMD and treating DOMS [1,6], the
use of complimentary therapy, in particular nutraceuticals
(e.g. tart cherry juice [9], curcumin [10], and quercetin
[11]) that possess anti-inflammatory properties and have
the potential to attenuate EIMD-induced oxidative stress,
have become of interest [1].One class of nutrients that appears to possess both
anti-inflammatory and anti-oxidant properties are the
long-chain omega (n)-3 long chain polyunsaturated fatty
acids (LC-PUFA), such as eicosapentaeoic acid (EPA;
20:5 n-3)) and docosahexaenoic acid (DHA; 22:5 n-3),
found in fish oil. Numerous studies have shown that n-3
LC-PUFA administered at doses greater than one gram
per day have beneficial actions in many inflammatory
diseases, cancer, and human health in general [12], and
that n-3 LC-PUFA may act as important energetic mole-
cules that can modulate immune, inflammatory, and oxi-
dative stress responses to exercise [13]. A small number
of studies have sought to evaluate whether fish oil sup-
plementation can reduce the degree of skeletal muscle
injury, inflammation and oxidative stress following ec-
centric exercise [13]. Although more studies have dem-
onstrated a positive effect of n-3 LC-PUFA in relation to
ameliorating muscle damage, DOMS, inflammation, and
oxidative stress following eccentric exercise [14-20],
some investigations have shown no effect [14,21]. It is
likely that the diversity in testing protocols, supplemen-
tation dosage and duration, subject population, timing of
measurements and selection of biomarkers contribute to
the discrepancies in the findings between studies. How-
ever, it is possible that different forms of marine oils
may have varying effects on these responses, since these
oils contain a variety of lipid mediators as well as a dif-
ferent amount of n-3 LC-PUFA.
PCSO-524® (Lyprinol®/Omega XL®) is a nutritional
supplement comprising of a patented extract of a very
condensed form of stabilized marine lipids from the
New Zealand green lipped mussel, Perna canaliculus,
combined with olive oil and vitamin E [22,23]. This mar-
ine oil lipid and n-3 PUFA blend is a multifarious mix-
ture of sterol esters, sterols, polar lipids, triglycerides,
EPA and DHA (split between the triacylglycerol and
polar lipid classes), and free fatty acids [24], and has
been shown to exert its anti-inflammatory effects via
furan fatty acids [25], and inhibition of cyclooxygenase
(COX)-2 and 5-lipoxyeganse (LOX) pathways for the
metabolism of arachidonic acid, thereby leading to a
subsequent reduction in pro-inflammatory leukotriene,
prostaglandin, and cytokine production from inflamma-
tory cells [22,26]. A number of human and animal stud-
ies have shown that the green-lipped mussel oil blend
may have beneficial effects in treating inflammatory
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flammatory bowel disease, asthma [22], and exercise- in-
duced bronchoconstriction [27]. These preliminary
findings support the potential for supplementation with
the green-lipped mussel oil blend in order to attenuate
muscle damage and inflammation that can occur follow-
ing muscle damaging exercise.
Therefore, the primary aim of the present study was to
evaluate the effects of supplementation with a green-
lipped mussel oil blend on indirect markers of muscle
damage, inflammation, and quadriceps fatigue following
muscle damaging exercise in untrained men. We hypothe-
sized that supplementation with a green-lipped mussel oil
blend, compared to placebo, would significantly reduce
blood markers of muscle damage and inflammation, and
modulate quadriceps fatigue and functional measures of
muscle damage following downhill running designed to
induce muscle damage in untrained men.
Methods
Subjects
Forty untrained males volunteered to participate in the
study, and of these thirty-two subjects (aged 22.0 ± 2 y,
height 176.3 ± 7.0 cm, body mass 70.8 ± 9.8 kg, maximal
oxygen consumption (VO2peak) 46.0 ± 6.1 mL∙kg
−1∙min
−1) completed the study. Reasons for the non- inclusion
of eight subject data sets in the final statistical analysis
were (1) subjects failing to show up at testing sessions
(incomplete data; n = 3), (2) inability of the investigators
to obtain a blood sample (incomplete data; n = 3), and
(3) identification of erroneous recordings of data (n = 2).
Subjects were classified as ‘untrained’ if they exercised
less than three times per wk for less than 30 min during
each session. Subjects were excluded if they had a his-
tory of significant pain in hips or knees, had participated
in a strength training program within 60 d prior to study
participation, or regularly used nutritional supplements
and over-the-counter and prescription anti-inflammatory
medication. All subjects were screened for coronary artery
disease risks factors as per the American College of Sports
Medicine guidelines [28]. Subjects were instructed to re-
frain from downhill running, stair running, resistance
training, plyometric or other mode of exercise that could
potentially cause muscle damage, and to refrain from
modifying their exercise habits during the course of the
study. Adherence to these instructions was confirmed at
each visit to the laboratory. The study was approved by
the Indiana University Institutional Review Board for Hu-
man Subjects, and written informed consent for all sub-
jects was obtained prior to participation in the study.
Study design
The study was conducted as a randomized, double-blind,
placebo-controlled parallel group trial over 30 days. Thisdesign was chosen over a crossover design in order to
avoid the repeated-bout effect acting as a confounding
variable [1]. Subjects were randomly assigned to either a
green-lipped mussel oil blend (PCSO-524®) supplementa-
tion group (n = 16) or a placebo group (n = 16). Supple-
mentation with the green-lipped mussel oil blend and
placebo began 26 days before an eccentric exercise bout
(downhill running, designed to induce muscle damage)
and continued for 4 days following the muscle damaging
exercise bout. An activity diary and food frequency ques-
tionnaire was completed by each subject during the course
of the study.
Pre-supplementation measures
After subjects provided written informed consent for
participation and the investigators explained the study
protocol, all subjects underwent an exhaustive 20-min
cycle ergometer familiarization test (T1 day −21),
followed one week later (T2 day −14) by an incremental
treadmill load test of their maximal oxygen uptake
(VO2max), in order to determine the intensity (70%
VO2peak) the subjects will exercise at for the eccentric
exercise test. One week (T3 day −7) following the
VO2peak test an initial (baseline) blood draw was taken
in order to measure baseline blood markers of muscle
damage, inflammation and DNA oxidative stress, along
with baseline functional measures of muscle damage [i.e.
isometric torque (MVC), knee flexion (joint range of mo-
tion), limb girth (swelling), muscle soreness, and muscle
pain], which were followed one week later (T4 day 0) by
measures of quadriceps muscle fatigue (quadriceps twitch
force measured via femoral magnetic nerve stimulation
before and after a 20-min exhaustive cycle ergometer
test).
Post-supplementation measures
Following the 26 days of supplementation a venous
blood draw was taken and functional measures of
muscle damage conducted (T5 day 26), which was dir-
ectly followed by the downhill running protocol specific-
ally designed to induce muscle damage [29,30] (T6 day
26). Immediately (T7 day 26) and 2 h following the
muscle damaging exercise a venous blood draw was
taken (T8 day 26), followed by additional blood draws
and functional measures of muscle damage at 24 h
(T9 day 27), 48 h (T10 day 28), 72 h (T11 day 29) and
96 h (T12 day 30) post-muscle damaging exercise.
Quadriceps muscle fatigue was measured 24 h following
the muscle damaging exercise bout (T8 day 27). The
timing of this measurement was chosen in order to cor-
respond with expected decrements in muscle strength,
range of motion and significant increases in swelling,
tenderness and soreness. On testing days T3 day −7, T5
day 26, T9 day 27, T10 day 28, T11 day 29 and T12 day
Table 1 Fatty acid composition (%) of PCSO-524®, a
marine oil extract of the New Zealand green-lipped mussel
(Perna canaliculus) * and placebo (olive oil) ** capsules







14:0 Myristic acid 1.7
16:0 Palmitic acid 13.4 9.2
16:1 Palmitoleic acid 3.6 3.0
18:0 Stearic acid 3.6 3.5
18:1 Oleic acid 58.2 81.0

























*Batch number: A6530-01. **Batch number: 7820. FA nomenclature: number of
carbon atoms (chain length), number of double bonds, and position of the last
double bond from the methyl (omega) end.
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order: blood draws, DOMS, range of motion, pressure
pain threshold, thigh girth (swelling) and isometric
torque (MVC). On testing T9 day 27 only, subjects
underwent the protocol for the measurement of quadri-
ceps muscle fatigue before and after the 20-min exhaust-
ive cycle ergometer trial.
Supplementation
Subjects ingested either 8 capsules per d of PCSO-524®
(Lyprinol®/Omega XL®; Pharmalink International Ltd,
Hong Kong) (n = 16), which equaled 800 mg olive oil,
400 mg lipid extract (~58 mg EPA and 44 mg DHA) and
1.8 mg vitamin E (d-alpha-tocopherol) or 8 placebo cap-
sules containing olive oil (1200 mg olive oil) (n = 16) for
30 d. Each PCSO-524® capsule contains 50 mg lipid ex-
tract (fatty acids), 7.3 mg (14%) EPA, 5.5 mg (11%)
DHA, 100 mg olive oil and 0.225 mg vitamin E, and 1
placebo capsule contains 150 mg olive oil. The active
PCSO-524® capsules containing the green-lipped mussel
oil blend were identical in size, color, texture and taste
to their respective placebo counterpart. Product specifi-
cation was provided to the investigators by the trial
sponsor (Pharmalink). Cawthron Laboratories (Nelson,
NZ), an independent laboratory, completed the fatty acid
analysis of the raw material, and Chemisches Labor
(Hannover, Germany) conducted the final fatty acid test-
ing of the finished PCSO-524 ® capsuled product. Alpha
laboratories (Auckland, NZ) conduced the fatty acid ana-
lysis on the placebo (olive oil) capsules. While Table 1
presents the fatty acid analysis conducted on the PCSO-
524® (Batch No. A6530-01) and placebo (Batch No.
7820) capsules used in the present study, a detailed fatty
acid analysis of the PCSO-524® and placebo capsules has
been published elsewhere [31,32]. Wolyniak et al. [23]
have shown that the ‘lipid extract’ portion of the green-
lipped mussel oil blend contains up to 91 fatty acids (in-
cluding EPA and DHA). Of the 91 fatty acids reported
[23], 16 represented more than 1% of the total FA. In de-
creasing order of abundance, these were EPA, C16:0
(Palmitic acid), DHA, C14:0 (Myristic acid), C16:1n-7
(Palmitoleic acid), C18:0 (Steroic acid), C18:1n-5,
C18:4n-3 (Stearidonic acid), C18:2n-6 (Linoleic acid),
C20:4n-6 (Arachidonic acid), C18:3n- 3 (Alpha-linoleic
acid), C16:1n-5, C20:1n-9 (Eicosenoic acid), C18:1n-9
(Oleic acid), C15:0 (Pentadecanoic acid), and C16:1n-9
(7-(hexadecenoic acid). PCSO-524® is a natural product
subject to variations in the New Zealand Marlborough
Sounds ecosystems. Values in the specification of this
organic compound can vary according to season and cli-
mate temperatures, and therefore, during the manufac-
turing process a variance of +/− 10% in the saturated,
monounsaturated and PUFA composition of PCSO-524®
is deemed acceptable.Experimental measures
Peak aerobic exercise capacity (VO2peak)
Subjects performed a peak aerobic exercise capacity test,
adapted from a previously published protocol from our
laboratory [33], on a motor driven treadmill (Model 18–
60, Quinton, Seattle, WA), while fitted with a heart rate
monitor (Polar Electro Inc., Lake Success, NY) and
breathing mask (7450 Series V2, Hans Rudolph, Shawnee,
KS USA). The protocol started with a warm-up period of
5 min, in which subjects chose a comfortable running
speed that they would be expected to be able to continue
on a level treadmill for 15 min; selected speeds ranged
from 7.2 – 13.8 km/h. After 5 min of seated rest, the exer-
cise portion of the test began with each subject running at
0% grade at a speed of 1.6 k/h less than the selected
(warm-up) speed for 2 min. Following the initial stage, the
speed was increased to the predetermined speed. After
3 min, the slope of the treadmill was increased to 4% for
3 min, and then increased an additional 2% every 3 min
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Ventilatory and metabolic data were collected using open-
circuit, indirect calorimetry. Dried expired gases were
sampled at a rate of 300 mL∙min−1 for fractional concen-
trations of O2 and CO2 using an Applied Electrochemistry
S-3A oxygen analyzer and a CD-3A carbon dioxide
analyzer (Ametek, Thermox Instruments, Pittsburgh, PA).
Inspired ventilation was measured with a pneumotach-
ometer (Hans Rudolph 3813).Eccentric muscle damaging exercise
All subjects performed a 20-min downhill running bout
on a motorized treadmill (A.R. Young Company, Indian-
apolis) modified to run in reverse at a −16% grade,
which is a protocol that has previously been shown to
elicit a significant degree of muscle damage following
downhill running [29,30]. Once the test commenced
subjects were not allowed to stop, and treadmill speed
was adjusted so that the subjects maintained a heart rate
that corresponded to 70% VO2max. It has been shown
that downhill running is effective in causing skeletal
muscle damage, symptoms of DOMS, and loss of muscle
force [34].Delayed onset muscle soreness and pain threshold
Lower limb soreness was assessed using a visual analog
(numeric) rating pain scale with “no soreness” indicated
at one end (score 0) and “unbearably painful” at the
other (score 10) Subjects stood with hands on hips and
feet approximately shoulder width apart. The subject
was asked to squat down to 90° (internal angle), rise to
the start position and then indicate on the numeric scale
the soreness felt in the lower limbs.
The pressure pain threshold was measured at five spe-
cific sites on the quadriceps with a digital algometer
(Force One, Wagner Instruments, Greenwich, CT.) to
quantify muscle tenderness. The same investigator per-
formed all measurements throughout the study. Specific
sites for assessment were determined using established
literature and landmarks [32], involving two anatomical
points (anterior superior iliac spine (ASIS) and superior
pole of the patella (SPP). All measurements were taken
on the right side with the subject in the supine position.
A longitudinal axis was created between the ASIS and
the SPP from which the sites were marked with a per-
manent marker to ensure accuracy at each time point.
The measured sites were: 15 cm distal to the ASIS,
4 cm proximal to the SPP, midpoint of the ASIS and
SPP along the axis, then 2 cm lateral and 2 cm medial
of this midpoint. Subjects were instructed to let the in-
vestigator know when the pressure transformed into
pain at which point the amount of force was recorded
in newtons (N).Range of motion (knee flexion), swelling (thigh girth) and
isometric strength (torque)
Range of motion has been shown to be an accurate
method of determining the extent of muscle damage
[35]. Subjects were instructed to lay prone on a massage
table with both knees fully extended. Subjects flexed
their left knee with no assistance from the investigator,
and the angle measured with a goniometer (Prestige
Medical, Northridge, CA) using universal landmarks
(lateral epicondyle of the femur, lateral malleolus and
greater trochanter) that were marked with a permanent
marker to ensure consistency on subsequent measures.
Three measurements were averaged and reported in de-
grees. This method for a assessing ROM has been vali-
dated previously [36].
In order to determine the presence of swelling/edema
within a muscle thigh circumference was assessed at the
midpoint of the ASIS and SPP of the right leg with an
anthropometric tape (Idass, Glastonbury, UK). Subjects
were standing fully relaxed in the anatomical position.
Subjects were instructed to put all their weight on the
opposite leg and 3 measurements were taken. Measure-
ment sites were marked to ensure consistent measure-
ments and the average was reported.
Isometric torque was assessed at a knee angle of 80°
using previously described protocol [37]. Subjects were
seated in a chair, secured with a belt across the legs and
chest, and their left leg secured to a force transducer
(Model Z Tension Load Cell, Dillon, Fairmont, MN)
with a non-compliant strap. Subjects were familiarized
with the equipment by performing three warm-up con-
tractions (two submaximal, 1 maximal) separated by
10 seconds of rest, followed by a 5 min recovery. After
the recovery period, subjects performed 3 maximum
voluntary contractions (MVCs) of the quadriceps, inter-
spersed with a 10 s recovery interval between contractions.
The highest peak torque from the 3 contractions was re-
corded. Subjects were verbally encouraged during the con-
tractions to produce a maximum effort.
Quadriceps muscle fatigue
Potentiated quadriceps twitch force was measured in the
subject’s left leg to quantify an index of muscle fatigue
following a 20 min exhaustive cycle ergometer test. Sub-
jects lay semirecumbent on a table with a left knee joint
angle of 90 degrees. The subject’s ankle was wrapped in
a non-compliant strap, placed just superior to the ankle
malleoli. The strap was attached to a calibrated load cell
(Model Z Tension Load Cell, Dillon, Fairmont, MN) for
the measurement of force connected to a custom ampli-
fier (Hector Engineering Co. Inc., Ellettsville, IN). A
magnetic stimulator (Magstim 200, Magstim, Whitland,
UK) connected to a double 70 mm coil was used to
stimulate the femoral nerve, causing an involuntary
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followed two protocols, which have been described pre-
viously [38].
Assessment of maximal nerve stimulation
Prior to the exhaustive 20 min cycle ergometer test, a
series of single twitches were obtained at varying levels
of stimulator intensity (80%, 85%, 90%, 95%, and 100%
of maximal stimulator power output) to determine when
supramaximal stimulation had been reached. The pos-
ition of the stimulator coil was placed over the femoral
triangle and adjusted to determine an acceptable loca-
tion for each subject. Stimulator placement was deter-
mined to be acceptable when repeatable and measurable
quadriceps contractions were obtained. Stimulator place-
ment was marked on the subject’s skin with an indelible
marker to insure repeatability of the location and meas-
urement. Typical stimulator output required to achieve
supramaximal stimulation has been found to be a mean
of approximately 83% of stimulator output [39].
Exhaustive 20 min cycle ergometer test
Following a 5 min warm up at a self-selected intensity,
subjects completed a 20 min exercise task on a cycle erg-
ometer (Velotron, RacerMate Inc., Seattle, Washington,
USA). Subjects were allowed to change resistance freely
and were asked to complete the furthest possible distance,
and to achieve the highest possible power output, during
the 20 min ergometer test.
Assessment of fatigue
Prior to and immediately following the exhaustive cycle
ergometer test, an assessment of quadriceps twitch force
(Qtw,pot) was performed. Twitch force prior to the
20 min cycle ergometer test was used as a baseline for
twitch force obtained after the time trial. The assessment
of fatigue protocol consisted of six repetitions of potenti-
ation and magnetic stimulation with 30 s of rest between
repetitions. For each repetition, subjects performed a
maximal voluntary isometric contraction (MVC) of the
quadriceps muscle for 5 s. At the end of the 5 s MVC,
the subject received a supra-maximal magnetic stimula-
tion of the femoral nerve, and a second stimulation after
5 seconds of rest [40]. The force produced during the
second twitch of each repetition was recorded as Qtw,pot.
Force values from the first two repetitions were dis-
carded based on previous findings that the degree of po-
tentiation is smaller after the first two measurements
[38]. Force values from the final four repetitions were
averaged to produce a Qtw,pot force value for each trial.
Blood sampling and analysis
All blood draws were taken from the antecubital vein
and collected into 10 ml plain Vacutainer® clot tubes(PulmoLab, Porter Ranch, CA). The tubes were gently
inverted five times after collection to mix the clot activator
with blood, and then placed on ice for at least 30 minutes
before centrifugation (Allegra ™ X-22R Centrifuge,
Beckman Coulter, Inc., Brea, CA) at 20°C at 3000 RPM
for 15 min. Serum was removed after spinning and al-
located to storage tubes and stored immediately at −80°C
until later analysis of muscle damage, inflammation and
oxidative stress markers using enzyme immunoassay tech-
niques [Powerwave XS™ Spectrophotometer (Bio-Tek
Instruments, Winooski, VT)] according to manufacturer’s
instructions.
Skeletal and cardiac muscle damage
Creatine kinase, muscle (CK-MM) was assessed using a
sandwich enzyme linked immunoassay test (sensitivity:
12.8 U/L; Detection range: 31.2 – 2,000 U/L. Intra-assay
precision: CV < 10%; Inter-assay precision: CV < 12% as
per the manufacturer’s (Caltag Medsystems Ltd, Milton
Keynes, UK) protocol. Skeletal muscle slow troponin I
(sTnI) was assessed using a sandwich enzyme linked im-
munoassay test (Minimum detectable concentration typ-
ically 5.4 pg/ml; Detection range: 15.6-1,000 pg/ml;
Intra-assay precision: CV < 10%; Inter-assay precision:
CV < 12% as per the manufacturer’s (USCN Life Science
Inc., Hubei, Peoples Republic of China) protocol. Myo-
globin (Mb) was assessed using an enzyme-linked im-
munoassay test (minimum detectable concentration:
5.0 ng/ml; sensitivity: 25 ng/ml; Detection range: 25.0-
1,000 ng/ml) following the manufacturer’s recommenda-
tions (Calbiotech, Spring Valley, CA, USA). Cardiac tropo-
nin I (CTnI) was analyzed a using sandwich enzyme-linked
immunoassay test (minimum detectable concentration:
0.45 ng/ml; Detection range: 0.48-5.0 ng/ml; inter-assay
precision: <10%) as per the manufacturer’s (Abnova, Taipei,
Taiwan) recommendations. Human heart fatty acid binding
protein (hFABP) was assessed using a sandwich enzyme
linked immunoassay test (minimum detectable concentra-
tion: 156 pg/ml; Detection range: 312 – 20,000 pg/ml.
Intra-assay precision: CV < 4-6%; Inter-assay precision:
CV < 8-10%) following the manufacturer’s (Innovative
Research, Novi, MI, USA) recommendations.
Inflammatory and DNA oxidative stress markers
Tumor necrosis factor (TNF)-α was assessed using a
sandwich enzyme linked immunoassay test (sensitivity:
1.7 pg/ml; Detection range: 15.6 – 1,000 pg/ml. Intra-assay
precision: CV < 4.4%; Inter-assay precision: CV < 7.5% as
per the manufacturer’s (Invitrogen Corp., Camarillo, CA,
USA) protocol. 8-Oxo-2'-deoxyguanosine (8-OhdG) was
analyzed using a competitive enzyme linked immunoassay
test (Detection range: 100 pg/ml – 20 ng/ml) as per the
manufacturer’s (Cell Biolabs Inc., San Diego, CA, USA)
recommendations.
Table 2 Subjects’ baseline characteristics
Green-lipped mussel




Age (years) 21.7 + 1.7 21.5 + 2.4 0.803
Height (cm) 178.1 + 5.8 174.2 + 6.7 0.091
Body mass (kg) 74.8 + 8.8 66.6 + 9.7 0.018*
BMI (kg/m2) 23.6 + 2.9 21.9 + 2.8 0.102
VO2peak (L) 3.4 + 0.5 3.0 + 0.6 0.073
VO2peak (ml/kg/min) 46.4 + 6.2 45.6 + 6.1 0.732
*Significantly different (p < 0.05) between groups. BMI, body mass index.
VO2peak, peak oxygen consumption. Values are expressed as mean ± SD.
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All subjects were given an activity diary to record fre-
quency, mode and duration of exercise. Nutrient intake
was monitored to ensure that dietary factors would do
not change through the course of the study, and poten-
tially affect the dependent measures. Nutrient data was
collected using the GSEL food frequency questionnaire
(FFQ) developed by the Nutrition Assessment Shared
Resource (NASR) of Fred Hutchinson Cancer Research
Center. Subjects completed the GSEL version of the
questionnaire before supplementation and at the end of
the 30 day supplementation period. Analysis of GSEL for
nutrient intake was conducted at the Fred Hutchinson
Cancer Research Center. Nutrients of interest obtained
from the GSEL analysis included macronutrient com-
position, antioxidants (α-tocopherol, β-carotene, lyco-
pene, Vitamin C), certain minerals (magnesium, sodium,
zinc), and types of dietary fatty acids (omega-3, total
polyunsaturated fatty acids, saturated fatty acids). While
the FFQ has been shown to be valid and reliable in the
collection of dietary data [41], we acknowledge that diet
may act as confounding factor, since it was not directly
controlled for in our study. Adherence to the treatment
regimen was monitored by asking the subjects to docu-
ment the dose of capsules consumed daily and to return
any unused capsules. For the purpose of the present
study a compliance of ≥90% was considered acceptable.
Data analysis
The data were analyzed using a two-way (group, 2; time,
6–8) split-plot repeated measures ANOVA using SPSS
version 20.0 (IBM Corporation, Chicago, IL, USA) statis-
tical software. The data was assessed for normality using
the Kolmogorov–Smirnov test, and Levene’s test was
used to test for homogeneity of variance between
groups. Mauchly’s test was be conducted to determine
whether sphericity is violated. If sphericity is violated,
the repeated-measures ANOVA was corrected using the
Greenhouse–Geiser correction factor. A fisher’s pro-
tected least-square difference post-hoc test was used a
priori to determine differences in dependent measures
within and between groups. Statistical significance was
set at p ≤ 0.05. Data are expressed as mean ± SD.
To determine an appropriate sample size for present
study, a post-hoc power analysis of existing literature
was conducted using G*Power version 3.0.5 (Universität
Kiel, Germany). Based on two studies [19,20] investigat-
ing the efficacy of n-3 LC-PUFA on DOMS, and blood
markers of muscle damage and inflammation following
eccentric exercise, achieving an experiment-wise error
rate of 0.05 required 15 subjects within each treatment
group. In these studies, Tartibian et al. [19,20] has shown
that ingestion of n-3 LC-PUFA (n = 9–15) for 30 days
compared to placebo/control (n = 9–15) significantlyreduced inflammatory markers, and perceived pain and
symptoms, following eccentric exercise, with effect sizes
ranging from 0.64-0.75 for a study power of 0.82 and
0.84 respectively.Results
Subject characteristics
There were no significant differences (p > 0.05) for age,
height, BMI, VO2max (L) and VO2peak (mL/kg/min) be-
tween the green-lipped mussel oil blend (PCSO-524™)
and placebo group (Table 2). However, body mass (kg)
was significantly different (p < 0.05) between groups.Delayed onset muscle soreness and pain threshold
Muscle soreness significantly increased (p < 0.05) in both
groups after the muscle damaging exercise protocol,
peaking between 24 and 48 h and declining toward base-
line at 72 and 96 h (Table 3). Significant effects for time
were found in the green-lipped mussel oil blend group
(p < 0.001) and placebo group (p < 0.001). Post-hoc pair-
wise comparisons between groups at each time point re-
vealed significantly lower DOMS in the treatment group,
compared to placebo, at 72 h [p = 0.027; mean difference
(Δ), 1.25 ± 2.41; 95% CI (difference of means), 0.08 to
2.52] and 96 h (p = 0.037; Δ, 1.25 ± 1.95; 95% CI, 0.13 to
2.63%) following muscle damaging exercise. However,
there were no significant differences (p > 0.05) between
groups prior to supplementation (baseline) and following
supplementation (before, and at 24 and 48 h following
muscle damaging exercise).
The test of within-subject effects indicated that there
was no significant effect (p > 0.05) of time on percent
change from baseline in all post-supplementation time
points for pressure pain threshold (PPT) values within
the green-lipped mussel oil blend group. Post-hoc pair-
wise comparisons within the placebo group revealed a
significant increase (p = 0.034; Δ, 0.12 ± 0.25%; 95% CI,
0.01 to 0.26%) in muscle tenderness at 24 h post-muscle
damaging exercise only compared to before muscle dam-
aging exercise in the placebo group (Table 3).










24 h after muscle
damaging exercise
48 h after muscle
damaging exercise
72 h after muscle
damaging exercise





2.3 ± 1.7 2.0 ± 2.0 4.9 ± 2.7¥,# 4.6 ± 2.2¥ 2.7 ± 1.7# 1.8 ± 1.6#
Placebo 1.9 ± 1.6 1.4 ± 1.5 4.4 ± 2.1¥, # 4.8 ± 1.8¥ 3.9 ± 1.8¥,# 3.0 ± 2.2¥,#
p-value* 0.700 0.563 0.847 0.441 0.029* 0.037*
Pressure Pain Threshold (% Δ from baseline)
Green-lipped
mussel oil blend
- −0.08 ± 0.32% −0.13 ± 0.26% −0.12 ± 0.28% −0.07 ± 0.34% −0.01 ± 0.34%
Placebo - −0.03 ± 0.35% −0.15 ± 0.27%# −0.10 ± 0.39% −0.07 ± 0.41% 0.01 ± 0.50%
p-value* - 0.643 0.844 0.824 0.978 0.896
Knee Flexion Range of Motion (degrees)
Green-lipped
mussel oil blend
47.5 ± 6.1 46.7 ± 5.0 47.4 ± 5.2 44.6 ± 5.9# 45.7 ± 5.4 46.7 ± 4.4
Placebo 45.8 ± 8.4 46.9 ± 9.8 47.3 ± 9.0 43.4 ± 7.1# 44.9 ± 8.5 41.8 ± 5.3¥
p-value* 0.476 0.939 0.980 0.628 0.760 0.007*
Thigh Girth (swelling) (% Δ from baseline)
Green-lipped
mussel oil blend
- 0.01 ± 0.02% 0.02 ± 0.02% 0.01 ± 0.02% 0.01 ± 0.02% 0.02 ± 0.04%
Placebo - 0.00 ± 0.02% 0.02 ± 0.02% 0.01 ± 0.02% 0.02 ± 0.02% 0.02 ± 0.06%
p-value* - 0.631 0.970 0.953 0.582 0.971
Maximum Voluntary Isometric torque (Strength) (Nm)
Green-lipped
mussel oil blend
72.8 ± 22.2 82.1 ± 19.7# 76.2 ± 19.8# 78.7 ± 21.5 79.9 ± 20.2 84.6 ± 22.4¥,#
Placebo 75.4 ± 19.3 82.1 ± 22.4# 74.9 ± 19.4# 74.6 ± 22.5 76.2 ± 20.8 83.9 ± 14.4




−27.8 ± 26.2 - −30.4 ± 14.3 - - -
Placebo −23.9 ± 24.0 - −39.5 ± 24.3¥ - - -
p-value* 0.669 - 0.039 - - -
*, p-value between groups at distinct time points (p < 0.05 denotes statistical significance between groups; p > 0.05 denotes no statistical significance between
groups); ¥, significantly different (p < 0.05) to pre- supplementation (baseline) within group; #, significantly different (p < 0.05) from previous time point within
group. Pressure pain threshold and thigh girth (swelling) are expressed as % change (Δ) from the pre- supplementation (baseline) value within group, since
baseline values were significantly different (p < 0.05) between groups. DOMS, delayed onset muscle soreness; % ΔQtw,pot, % change in potentiated quadriceps
twitch force from pre- to post-exercise (cycling time trial). Values expressed as mean ± SD.
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isometric strength (torque)
The test of within-subject effects indicated that there
was a significant effect (p < 0.01) of time on ROM within
each group. Range of motion was significantly reduced
(p < 0.05) at 48 h compared to 24 h post-muscle dam-
aging exercise within the green-lipped mussel oil blend
and placebo group. However, while no significant differ-
ence (p > 0.05) was found between groups for ROM
values at baseline and post-supplementation (prior to,
and at 24, 48 and 72 h post-muscle damaging exercise) asignificant reduction (p < 0.05) in ROM occurred in the
placebo group compared to the green-lipped mussel oil
blend group at 96 h post-muscle damaging exercise (p =
0.007; Δ, −4.94 ± 8.10 degrees; 95% CI, −1.42 to −8.45
degrees) (Table 2). No significant difference (p > 0.05)
was observed for the percent change from baseline in
thigh girth (swelling) within or between groups at all-
time points (Table 3).
The test of within-subject effects revealed that there
was a significant effect (p < 0.01) of time on MVC
(torque) within the both groups (Table 3). For both
Mickleborough et al. Journal of the International Society of Sports Nutrition  (2015) 12:10 Page 9 of 17groups post- supplementation MVC significantly in-
creased immediately prior to muscle damaging exercise
compared to the baseline value (Placebo: p = 0.009; Δ,
6.68 ± 10.1 Nm; 95% CI, 1.30 to 12.10 Nm. Green-lipped
mussel oil blend: p = 0.014; Δ, 9.41 ± 15.48 Nm; 95% CI,
1.16 to 17.66 Nm), and was significantly reduced at 24 h
post-muscle damaging exercise compared to the MVC
value obtained immediately prior to muscle damaging
exercise (Placebo: p = 0.002; Δ, 7.13 ± 8.4 Nm; 95% CI,
−2.65 to −11.61 Nm. Green-lipped mussel oil blend: p =
0.022, Δ, 6.02 + 11.00 Nm; 95% CI, −0.16 to −11.89 Nm).
In addition, within the green-lipped mussel oil blend
group only, MVC increased significantly at 96 h com-
pared to 72 h post-muscle damaging exercise (p = 0.014;
Δ, 4.67 ± 7.69 Nm; 95% CI, 0.57 to 8.77 Nm) and base-
line (p = 0.003; Δ, 11.83 ± 15.24 Nm; 95% CI, 3.71 to
19.95 Nm). No significant difference (p > 0.05) in MVC
was observed at any time point between groups.
Quadriceps muscle fatigue
There was no significant difference (p > 0.05) in the per-
cent change (%Δ) in Qtw, pot between groups at baseline,
or within the green-lipped mussel oil blend group when
comparing the %ΔQtw,pot at baseline with 24 h following
muscle damaging exercise. However, %ΔQtw,pot was sig-
nificantly greater at 24 h following muscle damaging
exercise compared to baseline within the placebo group
(p = 0.018 Δ, −11.4 ± 23.3%, 95% CI, −2.7 to −25.4%),
and %ΔQtw,pot was significantly greater for the placebo
group compared with the green-lipped mussel oil blend
group at 24 h following muscle damaging exercise (p = 0.039;
Δ, −10.1 ± 24.7%; 95% CI, −4.3 to −29.1%) (Table 3),Figure 1 Effect of supplementation on mean serum skeletal muscle s
exercise. *, designates a statistical difference (p < 0.05) between groups at
compared to baseline (BSLN; pre-supplementation before eccentric exercis
point within group. IM-PRE, immediately prior to eccentric exercise (post-suindicating greater muscle quadriceps fatigue in the pla-
cebo group.
Skeletal and cardiac muscle damage blood markers
Serum sTnI levels were not significantly different (p > 0.05)
for baseline (pre- supplementation), immediately prior to,
and immediately following (0 h) muscle damaging exercise
(post-supplementation) either within or between groups
(Figure 1). However, a significant increase (p < 0.05) in
serum sTnI concentration, compared to baseline, was ob-
served at 2, 24, 48, 72, and 96 h post- muscle damaging
exercise within each group. Serum sTnI concentration
peaked at 24 h following muscle damaging exercise, and
compared to baseline increased by 260.2 ± 170.6% in the
placebo group and by 165.1 ± 139.1% in the green-lipped
mussel oil blend group. There was a significant reduction
in the green-lipped mussel oil blend mean serum sTnI
concentration compared to the placebo group at 2 h
(p = 0.007; Δ, −4.5 ± 5.8 ng/ml; 95% CI, −0.9 to −8.0 ng/
ml), 24 h (p < 0.001; Δ, −9.9 ± 10.1 ng/ml; 95% CI, −4.4
to −15.4 ng/ml), 48 hr. (p < 0.001, Δ, −9.4 ± 10.0 ng/ml;
95% CI, −4.7 to −14.0 ng/ml), 72 h (p = 0.003; Δ, −6.8 ±
9.1 ng/ml; 95% CI, −2.5 to −11.1 ng/ml), and 96 h (p =
0.02, Δ, −5.4 ± 10.5 ng/ml; 95% CI, −0.3 to −10.4 ng/ml)
(Figure 1) following muscle damaging exercise.
Serum CK-MM levels were not significantly different
(p > 0.05) for baseline, and immediately prior to muscle
damaging exercise either within or between groups
(Figure 2). However, a significant increase (p < 0.05) in
serum CK-MM concentration, compared to baseline,
was observed at 0, 2, 24, 48, 72, and 96 h post-muscle
damaging exercise within each group. Serum CK-MMlow troponin I concentration (ng/ml) pre- and post-eccentric
distinct time points. #, designates a significant difference (p < 0.05)
e).ψ, designates a significant difference (p < 0.05) from previous time
pplementation). Data are expressed as mean ± SD.
Figure 2 Effect of supplementation on mean serum creatine kinase-MM concentration (ng/ml) pre- and post-eccentric exercise. *,
designates a statistical difference (p < 0.05) between groups at distinct time points. #, designates a significant difference (p < 0.05) compared to
baseline (BSLN; pre-supplementation before eccentric exercise).ψ, designates a significant difference (p < 0.05) from previous time point within
group. IM-PRE, immediately prior to eccentric exercise (post-supplementation). Data are expressed as mean ± SD.
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exercise for the placebo group and 72 h for the green-
lipped mussel oil blend group, and compared to baseline
increased by 1006.5 ± 631.2% in the placebo group and
by 579.8 ± 287.4% in the green-lipped mussel oil blend
group. A significant attenuation in the green- lipped
mussel oil blend mean serum CK-MM concentration,
compared to the placebo group, was detected at 0 h
(p < 0.001; Δ, −116.1 ± 112.0 ng/ml; 95% CI, − 63.0
to −169.2 ng/ml), 2 h (p < 0.001; Δ, −127.3 +
101.7 ng/ml; 95% CI, −76.0 to −178.6 ng/ml), 24 hr.
(p < 0.001; Δ, −386.1 ± 201.0 ng/ml; 95% CI, −562.6
to −775.6 ng.ml), 48 h (p < 0.001; Δ, −600.0 ± 208.5 ng/
ml; 95% CI, −493.2 to −706.7 ng/ml), 72 h (p < 0.001;
Δ, −463.7 ± 221.8 ng/ml; 95% CI, −360.0 to −568.0 ng/
ml) and 96 h (p < 0.001; Δ, −693.0 ± 243.0 ng/ml; 95%
CI, − 564.0 to −822.4 ng/ml) following muscle damaging
exercise (Figure 2).
Serum Mb levels were not significantly different (p > 0.05)
when comparing baseline, and immediately prior to and at
0 h and 2 h muscle damaging eccentric exercise either
within or between groups. However, a significant increase
(p < 0.05) in serum Mb concentration, compared to base-
line, was observed at 24, 48, 72, and 96 h post-muscle
damaging exercise within each group. Serum Mb concen-
tration peaked at 72 h following muscle damaging exercise
(post-supplementation) for both groups, and compared to
baseline increased by 1917.6 ± 876.3% in the placebo
group and by 1109.5 ± 496.2% in the green-lipped mussel
oil blend group. A significant attenuation in the green-
lipped mussel oil blend mean serum Mb concentrationcompared to the placebo group was observed at 24 h
(p < 0.001; Δ, −43.3 ± 37.1 ng/ml; 95% CI, −22.9 to −63.7 ng.
ml), 48 hr. (p < 0.001; Δ, −99.4 ± 58.7 ng/ml; 95% CI, −67.7
to −131.2 ng/ml), 72 h (p < 0.001; Δ, −192.6 ± 159.8 ng/ml;
95% CI, −119.0 to −226.3 ng/ml) and 96 h (p = 0.001;
Δ, −130.7 ± 161 ng/ml; 95% CI, − 49.1 to −212.2 ng/ml)
following muscle damaging exercise (post-supple-
mentation) (Figure 3). For serum cTnI and h-FABP
concentration no significant differences (p > 0.05) were
observed for all time points either within or between
groups.
Inflammatory and DNA oxidative stress markers
Mean serum TNF-α concentration did not significantly
differ (p > 0.05) for baseline, immediately prior to, and at
0 h following muscle damaging exercise either within or
between groups. However, a significant increase (p < 0.05)
in serum TNF-α concentration, compared to baseline, was
observed at 2, 24, 48, 72, and 96 h post-muscle damaging
exercise within each group. Serum TNF-α levels peaked at
24 h following muscle damaging exercise, and compared
to baseline increased by 156.2 ± 65.7% in the placebo
group and by 93.3 ± 49.4% in the green-lipped mussel oil
blend group. There was a significant reduction in mean
serum TNF-α concentration for the green-lipped mussel
oil blend group compared to the placebo group at 2 h
(p = 0.042; Δ, −4.9 ± 8.1 pg/ml; 95% CI, −0.4 to −10.6 pg/
ml), 24 h (p < 0.001; Δ, −19.8 ± 13.4 pg/ml; 95% CI, −11.1
to −28.5 pg/ml), 48 hr. (p < 0.001, Δ, −18.1 ± 12.7 pg/ml;
95% CI, −10.7 to −25.7 pg/ml), 72 h (p = 0.003; Δ, −19.9 ±
13.0 pg/ml; 95% CI, −11.3 to −28.5 pg/ml), and 96 h
Figure 3 Effect of supplementation on mean serum myoglobin concentration (ng/ml) pre- and post-eccentric exercise. *, designates a
statistical difference (p < 0.05) between groups at distinct time points. #, designates a significant difference (p < 0.05) compared to baseline (BSLN;
pre-supplementation before eccentric exercise).ψ, designates a significant difference (p < 0.05) from previous time point within group. IM-PRE,
immediately prior to eccentric exercise (post-supplementation). Data are expressed as mean ± SD.
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ml) following muscle damaging exercise (Figure 4).
Mean serum 8-OHdG concentration was not signifi-
cantly changed (p > 0.05) either within or between groups
for all time points.Figure 4 Effect of supplementation on mean serum tumor-necrosis fa
designates a statistical difference (p < 0.05) between groups at distinct time
baseline (BSLN; pre-supplementation before eccentric exercise).ψ, designate
group. IM-PRE, immediately prior to eccentric exercise (post-supplementatiNutrient intake and compliance
Mean daily nutrient intake, such as, for example, α-
tocopherol, β-carotene, lycopene, vitamin C, magnesium,
sodium, zinc, omega-3, total polyunsaturated fatty
acids and saturated fatty acids did not differctor-α concentration (pg/ml) pre- and post-eccentric exercise. *,
points. #, designates a significant difference (p < 0.05) compared to
s a significant difference (p < 0.05) from previous time point within
on). Data are expressed as mean ± SD.
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of the study. Compliance as estimated from return-
capsule count was high (median, 99%).
Discussion
The present study has shown that supplementing the
diet of untrained men for 4 wk with a marine oil lipid
and n-3 LC PUFA blend (PCSO-524®), derived from the
New Zealand green lipped mussel (P. canaliculus), sig-
nificantly reduced lower limb DOMS, quadriceps pain
(tenderness), and peripheral muscle fatigue, and pro-
vided a protective effect against ROM (knee flexion) and
isometric strength (torque) loss that can occur following
downhill running designed to induce muscle damage. In
addition, although blood markers of muscle damage and
inflammation, sTnI, CK-MM, MB, and TNF-α, signifi-
cantly increased following eccentric exercise in both
groups, the rise in these blood markers were significantly
suppressed on the green-lipped mussel oil blend supple-
mented diet compared to the placebo diet at most time
points following muscle damaging exercise. No signifi-
cant changes occurred between the green-lipped mussel
oil blend and placebo group following eccentric exercise
for swelling (thigh girth), and serum h-FABP, cTnI and
8-OHdG concentrations. Our findings may have impli-
cations for those who train regularly, especially since it
has recently been shown that EPA and DHA levels
(Omega-3 Index: percentage of EPA and DHA in total
erythrocyte fatty acids) were low in a cohort of German
elite winter endurance athletes [42], and importantly that
n-3 LC-PUFA supplementation leads to a higher Omega-3
index level and decreased incidence of DOMS in healthy
college aged individuals [43].
To date only two studies have been conducted in order
to determine the efficacy of supplementation with this
specific green-lipped mussel oil blend (PCSO-524®) on
markers of EIMD and DOMS following muscle dam-
aging [32] and exhaustive exercise [31]. While Baum
et al. [31] found that 11 wk. of the green-lipped mussel
oil blend supplemented diet reduced DOMS following
an exhaustive 30 km run in male and female trained dis-
tance runners, Pumpa et al. [32] found no effect of 8 wk
of supplementation with this specific green-lipped
mussel oil blend on DOMS and functional and blood
markers of EIMD following downhill running in trained
men from a variety of sports. The divergent findings be-
tween the present study and the Pumpa et al. study [32]
are difficult to reconcile, but is likely related to Pumpa
and colleagues [32] using a lower dose (600 mg/day) of
green-lipped mussel oil blend supplementation com-
pared to the present study (1200 mg/day), and using a
downhill running protocol of insufficient intensity to
promote muscle damage and a robust inflammatory re-
sponse in trained individuals.Effect of green-lipped mussel oil blend supplementation
on delayed onset muscle soreness and pain threshold
We observed a significant decrease in DOMS at 96 h
following muscle damaging exercise on the green-lipped
mussel oil blend supplemented diet compared to the pla-
cebo diet, which is in agreement with some studies
[15,17,19], but not all [14,21,32], that have shown that
supplementing the diet with n-3 LC-PUFA prior to
muscle damage attenuates DOMS following eccentric
exercise and a 30 km run [31]. Delayed-onset muscle
soreness appears many hours after muscle damaging ex-
ercise and peaks 24–72 h post-eccentric exercise [5], as
was observed in both groups in the present study. What
is clear is that while DOMS is not considered a disease
or a disorder, it can limit further exercise in the days fol-
lowing an initial training bout [3].
In the present study the quadriceps pressure pain
threshold (PPT) was used as an additional measure of
muscle soreness in an attempt to ameliorate the subjective
nature of the visual analog scale measure of soreness. We
observed no change in the PPT for all time points within
the green-lipped mussel oil blend group or between
groups. However, in the placebo group perceived pain in-
creased significantly 24 h following muscle damaging ex-
ercise compared to before muscle damaging exercise.
These data seem to suggest that the green- lipped mussel
oil blend supplemented diet may have afforded a protect-
ive effect against perceived pain developing in the quadri-
ceps, and may be partially explained by the attenuation in
muscle damage and the inflammatory response that oc-
curred in this group [5]. While Tartibian et al. [19] have
demonstrated that n-3 LC-PUFA supplementation for
30 days reduced perceived pain 48 hr. following eccentric
exercise compared to placebo, other studies [16,21,32]
have found no change in perceived pain following eccen-
tric exercise when pre- treated with n-3 LC-PUFA.
Effect of green-lipped mussel oil blend supplementation
on range of motion (knee flexion), swelling (thigh Girth)
and isometric strength (torque)
Among the numerous indirect markers of EIMD, muscle
function measures such as muscle strength (MVC
torque) and ROM are considered the best tools for
quantifying muscle damage [2]. Eccentric-biased down-
hill running protocols typically generate 10-30% force
loss after exercise, and that the reduction in MVC
torque resulting from injury persists until the muscle
function returns to its pre-injury condition (~24 h) [2].
Strength losses following eccentric exercise are likely
due to the effects of muscle damage, and evidence sug-
gests that excitation-contraction coupling failure plays a
role [44]. In the present study there were no significant
change observed for MVC torque at all-time points be-
tween groups or within the placebo group. However,
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line (pre- supplementation) at 96 h following muscle
damaging exercise on the green-lipped mussel oil blend
supplemented diet. In support of this finding of an in-
crease in muscle strength, Rajabi et al. [17] observed a
significant increase in isotonic voluntary contractile
strength of the quadriceps 24, 48 and 72 h following leg
press eccentric exercise on a 30 day n-3 LC-PUFA sup-
plemented diet compared to a placebo diet. Conversely,
Gray et al. [14] observed no changes in MVC torque fol-
lowing 200 eccentric knee contractions, while Pumpa
et al. [32] and Lenn et al. [21] observed no difference in
muscle strength of the right and left quadriceps and
non-dominant arm respectively between a placebo and
n-3 LC-PUFA supplemented diet.
Many studies have documented decreases in the vol-
untary ROM (~20-45 degrees) following eccentric exer-
cise, with full recovery not achieved until 10 days after
exercise [44]. The mechanism to explain this decrease
has been attributed to an increase in resting cytosol cal-
cium levels, ultrastructure damage and/or an increase in
fluid accumulation (swelling), and the measurement of
joint ROM in muscle damage studies has been used as
an indicator of passive muscle stiffness and soreness
[45]. Our data indicate that muscle damaging exercise
induced no loss of ROM in the green-lipped mussel oil
blend group. However, within the placebo group ROM
was significantly reduced (~4 deg) at 96 h post-muscle
damaging exercise compared to baseline, and was sig-
nificantly less (~4.9 deg) at 96 h following muscle dam-
aging exercise on the placebo diet compared to the
green-lipped mussel oil blend supplemented diet®. The
protective effect provided by the n-3 LC-PUFA rich diet
against ROM loss in the present study is similar to Tarti-
bian et al. [19] and Rajabi et al. [17] who observed that
on a n-3 LC-PUFA supplemented diet, compared to a
placebo diet, the loss of knee ROM was significantly less
post-eccentric bench stepping exercise and leg press ec-
centric exercise respectively, but are in contrast to the
findings of Lenn et al. [21] and Phillips et al. [21] who
observed no change in joint ROM following eccentric
elbow flexion exercise.
Although swelling has been shown to occur following
eccentric exercise and to be associated with the mecha-
nisms of DOMS induced by eccentric exercise [46],
there are studies that have shown a dissociation between
when swelling and DOMS occur following eccentric ex-
ercise. Rodenburg et al. [47] have shown that MRI
changes indicating the presence of edema do not to co-
incide with soreness following eccentric exercise (left
forearm flexors) [47], while Clarkson et al. [35] noted
that peak soreness occurred 2–3 d post-eccentric exer-
cise (forearm flexor muscles) while peak swelling oc-
curred 5 d following maximal effort eccentric actions ofthe forearm flexor muscles, while Yu et al. [48] has dem-
onstrated that eccentric exercise (downstairs running)
does induce muscle fiber swelling (soleus muscle), but it
emerges at 7–8 d, and not at 2–3 d post-eccentric exer-
cise when DOMS peaked. Based on the data from these
studies [35,47,48] it is possible that we missed a poten-
tial effect of treatment on limb girth (swelling) since our
final measurement of limb girth was at 96 h post-
muscle damaging exercise.
Effect of green-lipped mussel oil blend supplementation
on quadriceps muscle fatigue
Potentiated quadriceps twitch force (Qtw,pot) assessed via
magnetic stimulation before and after a 20-min cycling
time trial pre- and post-supplementation (24 h following
muscle damaging exercise) was used to quantify the degree
of quadriceps muscle fatigue (ΔQtw,pot). The measurement
of quadriceps twitch force produced by supramaximal
magnetic stimulation of the femoral nerve has been shown
to be a reliable method to detect quadriceps fatigue fol-
lowing loading [38,40,49]. This study has shown for the
first time in humans that n-3 LC-PUFA supplementation
provided a protective effect against the development of
quadriceps muscle fatigue following a 20 min exhaustive
cycling ergometer test compared to placebo supplementa-
tion. While the %ΔQtw,pot was unaltered between pre- and
post- supplementation (24 h following muscle damaging
exercise) for the green-lipped mussel oil blend group,
there was a significant decline (~65%) in the %ΔQtw,pot
post-supplementation compared to pre-supplementation
for the placebo group. Our data are in agreement with
animal studies [50,51] that have shown that rats fed fish
oil, hindlimb skeletal muscle were more resistant to fa-
tigue during continuous muscle twitch contractions, and
recovered contractile force better between repeat bouts,
compared to an n-6 LC-PUFA or saturated fat enriched
diet.
Effect of green-lipped mussel oil blend supplementation
on blood markers of muscle damage, inflammation and
DNA oxidative stress
Although a few studies have shown that eccentric exer-
cise leads to myofibrillar remodeling specifically through
Z-band related proteins, rather than muscle necrosis and
inflammation [48,52], we have shown that supplement-
ing the diet with a green-lipped mussel oil blend can
mitigate the rise in a number of indirect markers of skel-
etal muscle damage and inflammation, and this effect
persists for up to 96 h following muscle damaging
exercise.
Slow skeletal troponin I is considered an early marker
of EIMD, since it is particularly susceptible to calpain di-
gestion, which may contribute to the early rise in plasma
sTnI levels following eccentric exercise [53]. Our data
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loughby et al. [54] that a significant increase in serum
sTnI can be detected within 2 h following muscle dam-
aging exercise, and peaks within 24 h after the muscle
injury- inducing sessions. In addition, we have shown for
the first time that n-3 LC-PUFA supplementation can
mitigate the increase in serum sTnI following muscle
damaging exercise.
We observed a significant attenuation in serum Mb
concentration in the green-lipped mussel oil blend
group, compared to the placebo group, at 24, 48, 72 and
96 h following muscle damaging exercise, which is simi-
lar to the findings from a previous study [20] that
showed that 30 d of n-3 LC-PUFA supplementation can
moderate the rise in serum Mb at 24 and 48 h after ec-
centric exercise in untrained men. Myoglobin is an
oxygen-binding heme protein found in skeletal and car-
diac muscle, and thus is not specific for skeletal muscle,
and h- FABP, which is involved in the transport and me-
tabolism of fatty acids, is found in higher concentrations
in the heart compared to human skeletal muscle [53].
However, both myoglobin and h-FABP have been pro-
posed as useful markers of skeletal muscle injury in the
absence of cardiac damage [30]. In the present study we
did not observe any significant change in serum cTnI or
h-FABP following muscle damaging exercise at any time
point within either group, which suggests that the in-
crease in serum myoglobin following muscle damaging
exercise was likely the result of skeletal and not cardiac
muscle damage.
Myofibrillar CK-MM is a cytosolic enzyme specifically
bound to the myofibrillar M-line structure located in the
sarcomere, and is also found in the space of the I-band
sarcomeres where it provides support for muscle energy
requirements. Whist we found that serum CK- MM
significantly increased immediately following muscle
damaging exercise and remained elevated in both groups
for a further 96 h, there was a significant attenuation in
serum CK- MM in the green-lipped mussel oil blend
group, compared to the placebo group, for all-time points
following muscle damaging exercise. A number of studies
assessing the efficacy of n-3 LC-PUFA supplementation
on EIMD and DOMS have not used serum CK-MM, but
rather total serum CK concentration as an indirect marker
of muscle damage. Given that total serum CK has not
been shown to correlate with histological evidence of skel-
etal muscle damage [55] it is not surprising that consider-
able variability is observed in this blood marker among
studies assessing the impact of n-3 LC-PUFA supplemen-
tation on muscle damage and DOMS following eccentric
exercise [14,16,17,20,21,32].
An important aspect associated with the initiation and
amplification of acute inflammation is the production of
cytokines that are synthesized de nova by lymphocyte’sand monocytes at the site of muscle injury, and aid in
directing inflammatory-related events [56]. At the onset
of inflammation there is an upregulation of the pro-
inflammatory cytokines interleukin-1β, and tumor-
necrosis factor (TNF)-α. While IL-1β and TNF-α are
most likely released by resident macrophages at the site
of injury [56], and initiate the inflammatory response,
TNF- α, in particular, has been shown to play a signifi-
cant role in the muscle regeneration phase following
muscle injury [57,58]. While we observed a significant
increase in TNF-α for both groups following muscle
damaging exercise, with serum TNF-α peaking at 24 h
post-muscle damaging exercise, and remaining elevated
for up to 96 h, the serum concentration of TNF-α was
significantly lower in the green-lipped mussel oil blend
group compared to the placebo group. At present the
data are conflicting as to whether n-3 LC-PUFA can
suppress the inflammatory response following eccentric
exercise [16,20,21,32].
Oxidative stress-induced muscle damage has been
shown to be associated with muscle soreness, and the
resultant generation of free radicals causes oxidative
damage to cellular DNA [59]. 8-hydroxy-2’ –deoxygua-
nosine (8-OHdG) is a product of oxidative DNA damage
induced by the action of hydroxyl radicals on the DNA
base deoxyguanosine (dG) and DNA single-strand
breakage, and represents the most frequently used
marker to assess DNA damage. Serum 8-OHdG has
been shown to increase following eccentric isokinetic ex-
ercise in humans [59], but not after downhill running in
rats [60] or humans [61]. In the present study we ob-
served no significant increase in serum 8-OHdG follow-
ing muscle damaging exercise in both groups compared
to baseline, and no significant difference in serum 8-
OHdG between groups at any time point. The lack of
change in serum 8-OHdG following muscle damaging
exercise does not exclude the possibility that changes in
this marker were present in the active skeletal muscle, as
the serum concentration 8-OHdG may be diluted in
comparison with the actual site of generation (within
muscle). In addition, the intensity/duration of the stimu-
lus may not have been sufficient to overwhelm the
body’s endogenous antioxidant system, and/or an upreg-
ulation of protective mechanisms against DNA damage
developing [59], may have also played a role. It is sur-
prising that serum 8- OhdG was not increased following
muscle damaging exercise, especially given that struc-
tural protein within skeletal muscle was damaged (i.e. in-
crease in serum sTnI). Changes in oxidative stress
observed following muscle damaging exercise may not
be the same when comparing blood and skeletal muscle,
and thus we acknowledge that a limitation to our study
is that we did not include additional biomarkers of oxi-
dative stress.
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pain and may well impair skeletal muscle function it
does appear that inflammation represents a critical as-
pect of skeletal muscle repair and regeneration, and
therefore blocking the inflammatory response with either
pharmacological drugs or nutraceuticals may well hinder
recovery [62]. With this in mind an important question
that needs to be resolved is whether the most beneficial
course of treatment should be to inhibit the inflamma-
tory response or to let it progress naturally. Therefore, if
there is a benefit in blocking inflammation, when is the
appropriate time to do so and for how long post-muscle
injury? While post-treatment of skeletal muscle injury is
likely a more practical tactic, regardless of whether the
injury is acute or slower to materialize such as with re-
petitive use injuries, it is not known at present whether
n-3 LC-PUFA supplementation would be as effective in
ameliorating EIMD and the inflammatory response if
delivered post-injury only. This is an important question
to answer since in some cases of skeletal muscle injury
pre-treatment with anti-inflammatory agents for long
periods of time is not always a realistic option for an
individual.
Anti-inflammatory mechanisms of action of PCSO-524®
In the present study the attenuation of a number of in-
direct markers of EIMD and inflammation cannot be ex-
plained entirely by the EPA and DHA content of PCSO-
524®, since the total amount of EPA and DHA content
consumed daily was 58 mg and 44 mg respectively,
which are considerably lower amounts than previous
studies [14-20] that have demonstrated a positive effect
of n-3 LC-PUFA supplementation (0.3 - 2.0 g EPA/day
and 0.2 – 1.0 g DHA/day) on mitigating EIMD, DOMS
and inflammation. It has been shown the green-lipped
mussel oil blend used in the present study, which con-
tains up to 91 fatty acid components [23], has more
potent anti-inflammatory activity than fish oil, which
contains abundant EPA, in various animal models of
arthritis, and inflammatory bowel disease [22]. There-
fore, it is possible that additional constituents of the
green-lipped mussel oil blend, which may act synergis-
tically with the n-3 LC-PUFA, may also be partially re-
sponsible for its anti-inflammatory effects. The green-
lipped mussel oil blend contains polyphenols (oleuropein
and hydroxtyrosol) and oleic acid, which are anti-
inflammatory, and postulated to reduce risk factors for
heart disease, lower cancer mortality, and reduce inflam-
mation [22,63]. It has been shown that furan fatty acids,
which are a minor component of the green- lipped
mussel oil blend, exhibit more potent anti-inflammatory
activity than EPA in a rat model of adjuvant-induced
arthritis [25], and which possess potent free-radical scav-
enging abilities [64], may explain, at least in part, why inthe present study the green-lipped mussel oil blend was
effective in attenuating EIMD, DOMS and inflammation,
given the very low dose of EPA and DHA.
Conclusion
In conclusion, the present study has shown that supple-
menting the diet of untrained men for 30 days with
1200 mg/d of a marine oil lipid and n-3 LC PUFA blend
(PCSO-524®), derived from the New Zealand green
lipped mussel, attenuated indirect markers of muscle
damage and inflammation following downhill running
designed to induce muscle damage, and may represent a
useful therapeutic agent for mitigating muscle damage
and inflammation following unaccustomed and/or ec-
centric exercise.
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